ICCR Symposium - ESC Annual Congress 2008
Targeting abdominal obesity and the metabolic syndrome to optimally manage global cardiovascular disease risk: exploring opportunities for prevention
European Society of Cardiology (ESC)
Symposium on Cardiometabolic Risk
Targeting abdominal obesity and the metabolic syndrome to optimally manage global cardiovascular disease risk: exploring opportunities for prevention
Room: Athens – Zone B3
Time: 11:00-12:30
Chairpersons: J.P. Bassand and Pekka Puska
| 11:00 - 11:20 | Assessing the metabolic syndrome: does it matter in the evaluation of global cardiovascular disease risk? | S.M. Haffner USA |
| 11:22 - 11:42 | Abdominal obesity, metabolic syndrome and cardiovascular disease risk: the interventional cardiologist's perspective | P.G. Steg France |
| 11:44 - 12:04 | Treating hypertension in the metabolic syndrome: is there a preferred drug? | L.M. Ruilope Spain |
| 12:06 - 12:26 | Modifying lifestyle to reduce cardiovascular disease risk in patients with the metabolic syndrome: is weight loss the right target? | J.P. Després Canada |